Pnd60 Acetylcholinesterase Inhibitor - Associated Antipsychotic Prescribing Cascade Among Older Adults With Dementia

Abstract

95% CI 1.49-2.25) and high disease severity (HR = 6.42, 95% CI 5.07-8.13) groups had increased risk compared to the low disease severity reference group. When both eligibility and disease severity were considered simultaneously, the risk increased for both relapses and hospitalizations as disease severity increased. The eligibility types, however, did not appear to have a clear pattern across MS risk groups for either MS relapse or hospitalizations. Conclusions: Among MS patients, an algorithm-determined disease severity categorization appears consistent with relapses and hospitalizations, traditional claims-based measures of disease severity.